Shalvaton

Shalvaton Brand names, Shalvaton Analogs

Shalvaton Brand Names Mixture

No information avaliable

Shalvaton Chemical_Formula

C₂₀H₂₃NS

Shalvaton RX_link

No information avaliable

Shalvaton fda sheet

Shalvaton msds (material safety sheet)

Shalvaton Synthesis Reference

No information avaliable

Shalvaton Molecular Weight

309.469 g/mol

Shalvaton Melting Point

< 25 ^oC

Shalvaton H₂O Solubility

Soluble as HCl salt

Shalvaton State

Liquid

Shalvaton LogP

5.7

Shalvaton Dosage Forms

Tablets (oral, 1 mg)

Shalvaton Indication

Used for the symptomatic treatment of parkinsonism.

Shalvaton Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Shalvaton Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Shalvaton side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Shalvaton Patient Information

Shalvaton Organisms Affected

Humans and other mammals